Page last updated: 2024-11-03

prazosin and Fecal Incontinence

prazosin has been researched along with Fecal Incontinence in 2 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Fecal Incontinence: Failure of voluntary control of the anal sphincters, with involuntary passage of feces and flatus.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rayment, SJ1
Eames, T1
Simpson, JA1
Dashwood, MR1
Henry, Y1
Gruss, H1
Acheson, AG1
Scholefield, JH1
Wilson, VG1
Holmes, SA1
Christmas, TJ1
Wood, JJ1
Kirby, RS1

Other Studies

2 other studies available for prazosin and Fecal Incontinence

ArticleYear
Investigation of the distribution and function of alpha-adrenoceptors in the sheep isolated internal anal sphincter.
    British journal of pharmacology, 2010, Volume: 160, Issue:7

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-A

2010
Faecal incontinence resulting from alpha 1-adrenoceptor blockade.
    Lancet (London, England), 1990, Sep-15, Volume: 336, Issue:8716

    Topics: Anal Canal; Fecal Incontinence; Humans; Male; Middle Aged; Prazosin

1990